Yahoo Web Search

  1. AstraZeneca plc (NYSE: AZN) and partner DAIICHI SANKYO/S ADR (OTC: DSNKY) announced positive news Thursday on their HER-2 targeting antibody drug conjugate, or ADC. This should ...

  2. AstraZeneca Plc said on Thursday that the U.S. drug regulator will give a speedy review to its experimental breast cancer treatment, which could put the British drugmaker in direct ...

  3. Here Are Some of the Big Stock Winners If Brexit Deal Gets Done

    Bloomberg via Yahoo FinanceOct 12 7:00 AM

    U.K. domestic stocks may shake off their pariah status as beaten-down banks, housebuilders and retailers would be the biggest winners if the U.K. and European Union agree a deal on Brexit before ...

  4. Drugmaker AstraZeneca Plc said on Thursday its experimental breast cancer treatment will get a speedy review by the U.S. Food and Drug Administration, with a decision by the health ...

  5. Innate Pharma IPO: What You Need To Know

    Benzinga via Yahoo FinanceOct 15 17:26 PM

    A commercial-stage French biotech with expertise in oncology drug development is testing the IPO waters this week. France-based Innate Pharma S.A. is proposing to offer 10.67 million shares ...

  6. Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. TerraForm Power Inc ...

  7. IPO Outlook For The Week: Cancer Therapies And Protein Powders

    Benzinga via Yahoo FinanceOct 14 12:21 PM

    Bellring Brands, Inc. NYSE: BRBR) will issue 30 million shares between $16 and $19 Thursday on the New York Stock Exchange. The offering represents 100% of outstanding shares and is expected to raise about $655.5 million.